Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Newcastle University has entered into a lease agreement with Curium for a new site dedicated to the manufacture of cutting-edge diagnostic technologies for diseases such as cancer. The facility will...
-
PETTEN, The Netherlands, May 21, 2025 (GLOBE NEWSWIRE) -- NRG PALLAS and Curium have extended their collaboration to produce molybdenum-99 through a new multi-year agreement. Molybdenum-99, which...
-
Swissmedic grants marketing authorization for PYLCLARI® in Switzerland b.e. Imaging is marketing authorization holder and has exclusive distribution rights for PYLCLARI® across Switzerland ZURICH,...
-
The acquisition of Nucleis will: Enhance Curium’s PET manufacturing capacity and radiopharmaceutical distribution network of 32 PET sites in Western EuropeImprove reliability and accessibility...
-
ST. LOUIS, April 02, 2025 (GLOBE NEWSWIRE) -- Curium announced today that the U.S. Food and Drug Administration approved its generic version of the Kit for the Preparation of Technetium Tc 99m...
-
วางตำแหน่ง Curium เป็นผู้ผลิตไอโซโทป Lu-177 ชั้นนำนำความเชี่ยวชาญด้านการวิจัยและพัฒนาที่เป็นนวัตกรรมและลำดับขั้นตอนการทำงานมาสู่ Curiumเพิ่มความครอบคลุมทางภูมิศาสตร์และห่วงโซ่อุปทาน SPECT & PET...
-
Posiciona a Curium como fabricante líder de isótopo Lu-177Aporta experiencia innovadora en I+D y una línea de desarrollo de productos a CuriumMejora la cobertura geográfica y la cadena de suministro...
-
Curium, 루테튬-177 동위원소 선도적 제조업체로 자리매김Curium은 혁신적인 R&D 전문성과 파이프라인 확보 효과Curium의 SPECT 및 PET 지리적 범위와 공급망 강화 파리, March 29, 2025 (GLOBE NEWSWIRE) -- 핵의학 분야를 선도하는 Curium Pharma(이하 “Curium”)가 터키 이스탄불에...
-
Menempatkan Curium sebagai produsen terkemuka isotop Lu-177Memberikan keahlian Litbang dan rangkaian tahap pengembangan produk (pipeline) yang inovatif ke CuriumMeningkatkan jangkauan geografis dan...
-
确立了 Curium 的镥-177 同位素领先制造商地位为 Curium 注入创新的研发专业技术和产品管线拓展 Curium 的 SPECT 和 PET 地理覆盖范围和供应链 巴黎, March 29, 2025 (GLOBE NEWSWIRE) -- 全球核医学领域领导者 Curium Pharma (“Curium”) 宣布完成对 Eczacıbaşı-Monrol Nuclear...